<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Agilent: Podcast</title>
    <description>Podcast Conversations with Agilent Executives</description>
	<link>http://www.agilent.com/about/newsroom/lsca/podcast/</link>
	<copyright>Copyright 2011 Agilent</copyright>
    <language>en-us</language>
	<lastBuildDate>Mon, 19 Mar 2012 16:00:00 PDT</lastBuildDate>
   <pubDate>Mon, 19 Mar 2012 16:00:00 PDT</pubDate>
    <docs>http://www.agilent.com/about/newsroom/lsca/podcast/</docs>
    <managingEditor>stuart_matlow@agilent.com (Stuart Matlow)</managingEditor>
	<atom:link href="http://www.agilent.com/about/newsroom/rss/agilent-news-lsg-podcast.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>http://www.agilent.com/about/images/logo_main.gif</url>
      <title>Agilent: Podcast</title>
      <link>http://www.agilent.com/about/newsroom/lsca/media/index.html#audio</link>
    </image>
    <item>
      <title>Agilent Genomics vice president and general manager Bob Schueren</title>
      <link>http://www.agilent.com/about/newsroom/lsca/media/index.html#audio</link>
	  <guid>http://www.agilent.com/about/newsroom/lsca/podcast/audio/2012-003-schueren-interview.mp3</guid>
	  <description>Agilent Genomics vice president and general manager Bob Schueren talks about the major steps Agilent is taking to move research technology into the clinic. These include the recent launch of SureFISH probes, Haloplex, Methyl-Seq. and the registration of facilities as medical device facilities.</description>
      <enclosure url="http://www.agilent.com/about/newsroom/lsca/podcast/audio/2012-003-schueren-interview.mp3" length="7356416" type="audio/mpeg"/>
	  <category>Speaker</category>
	  <pubDate>Mon, 19 Mar 2012 16:00:00 PDT</pubDate>
    </item>
    <item>
      <title>Research Products Division: Moving Forward with Regina Schuck</title>
      <link>http://www.agilent.com/about/newsroom/lsca/media/index.html#audio</link>
	  <guid>http://www.agilent.com/about/newsroom/lsca/podcast/audio/2011-002-schuck-interview.mp3</guid>
	  <description>Agilent Research Products Division vice president and general manager Regina Schuck describes how the recently-acquired nuclear magnetic resonance spectroscopy products are complementary to Agilent’s mass spectrometry portfolio. She also talks about the company’s plans to drive technological advances in NMR.</description>
      <enclosure url="http://www.agilent.com/about/newsroom/lsca/podcast/audio/2011-002-schuck-interview.mp3" length="10892701" type="audio/mpeg"/>
	  <category>Speaker</category>
	  <pubDate>Tue, 26 Jul 2011 08:00:00 PDT</pubDate>
    </item>
    <item>
      <title>Integrated Biology: On the Verge of Fueling Breakthroughs With Gustavo Salem</title>
      <link>http://www.agilent.com/about/newsroom/lsca/media/index.html#audio</link>
	  <guid>http://www.agilent.com/about/newsroom/lsca/podcast/audio/2011-001-salem-interview.mp3</guid>
	  <description>Agilent Biological Systems Division VP Gustavo Salem describes how advances in bioinformatics software is making multi-omics research a reality, giving scientists new tools to achieve breakthroughs in personalized medicine. They’re on the verge of finally realizing the promise of Systems Biology.</description>
      <enclosure url="http://www.agilent.com/about/newsroom/lsca/podcast/audio/2011-001-salem-interview.mp3" length="6879246" type="audio/mpeg"/>
	  <category>Speaker</category>
	  <pubDate>Fri, 01 Apr 2011 08:00:00 PDT</pubDate>
    </item>
  </channel>
</rss>
